RECALL: FDA recalls common heart medicine

RECALL: FDA recalls common heart medicine

FILE - This Oct. 14, 2015, file photo shows the Food and Drug Administration campus in Silver Spring, Md. The FDA said Thursday, July 12, 2018, it plans to more aggressively fight the persistent medication shortages that have led to rationing, disrupted hospital operations and even compromised patient care. It?s a new approach for the drug regulator, which has typically waited until shortages began or were imminent to take action. (AP Photo/Andrew Harnik, File)

CHARLOTTE, N.C. — The Food and Drug Administration (FDA) is recalling a common heart medicine.

The FDA recalled val-sartan because they believe it may be putting patients at risk for cancer.

Content Continues Below

The administration said the drug does not meet its safety standards and contains a chemical that is linked to causing cancer.

High amounts of this chemical cam also cause liver damage.

Nearly two dozen other countries have recalled the drug within the last week.

Read more top trending stories on